Pegcrisantaspase
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Pegcrisantaspase, covering 2017-02-23 to 2025-10-07. Get the full timeline:
Most recent: Clinical Trial Update: Pegcrisantaspase in Combination With Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) [Phase 1]